George B. Abercrombie - 18 Apr 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
18 Apr 2022
Net transactions value
-$38,600
Form type
4
Filing time
20 Apr 2022, 16:23:20 UTC
Previous filing
16 Feb 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Options Exercise $16,600 +5,000 $3.32 5,000 18 Apr 2022 Direct F1
transaction BCRX Common Stock Sale $55,200 -5,000 -100% $11.04 0 18 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Automatic Stock Option Grant Options Exercise $0 -5,000 -100% $0.000000* 0 18 Apr 2022 Common Stock 5,000 $3.32 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
F2 The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012.